IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.
Free access to all Sound Bites content
Published on: October 23, 2025
Medical Professional
CM-9LA Biomarker
Dr. Tara Graff discusses the 5-year efficacy of Pola-R-CHP in LBCL (Video 1/3)
Tara Graff, MD
Dr. Eric Singhi describes differentiating safety aspects of cemiplimab in patients with aNSCLC (Video 3/3)
Eric Singhi , MD
Dr. Charu Aggarwal presents intracranial activity for datopotamab deruxtecan in pretreated mNSCLC (Video 3/3)
Charu Aggarwal, MD
Dr. Charu Aggarwal reviews safety highlights for datopotamab deruxtecan in pretreated mNSCLC (Video 2/3)
Charu Aggarwal, MD
Dr. Eric Singhi shows that PD-L1 expression is a spectrum in patients with aNSCLC (Video 2/3)
Eric Singhi , MD
Dr. Gregory Vidal discusses the safety, tolerability, and patient management techniques for inavolisib + palbociclib + fulvestrant in 1L PIK3CAm HR+, HER2- ABC (Video 2/2)
Gregory Vidal